关注
Anna Camps-Vilaró
Anna Camps-Vilaró
CIBER de Enfermedades Cardiovasculares, Instituto de Salud Carlos III
在 researchmar.net 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: the REGICOR study
IR Dégano, A Camps-Vilaró, I Subirana, N García-Mateo, P Cidad, ...
Journal of Clinical Medicine 9 (5), 1402, 2020
262020
Estimated population prevalence of heart failure with reduced ejection fraction in Spain, according to DAPA-HF study criteria
A Camps-Vilaró, JF Delgado-Jiménez, N Farré, H Tizón-Marcos, ...
Journal of clinical medicine 9 (7), 2089, 2020
122020
Analysis of myocardial infarction incidence and case-fatality in the last three decades in the province of Girona
A Camps-Vilaró, I Subirana, R Elosua, I Palomo, J Sanchis, ...
Revista Española de Cardiología (English Edition) 77 (6), 450-458, 2024
42024
Socioeconomic status and prognosis of patients with ST-elevation myocardial infarction managed by the emergency-intervention “Codi IAM” network
H Tizón-Marcos, B Vaquerizo, JM Ferré, N Farré, RM Lidón, ...
Frontiers in cardiovascular medicine 9, 847982, 2022
32022
Standardized comparison of cardiovascular risk factors prevalence in Spanish women and men living with HIV and in the general population
A Camps-Vilaró, S Pérez-Fernández, I Subirana, R Teira, V Estrada, ...
Journal of Personalized Medicine 11 (11), 1085, 2021
22021
Five-Year Changes in Inflammatory, Metabolic, and Oxidative Biomarkers and 10-Year Cardiovascular Disease Incidence: The REGICOR Cohort Study
A Camps-Vilaro, I Subirana, R Ramos, M Cainzos-Achirica, ...
International Journal of Molecular Sciences 24 (9), 7934, 2023
12023
No las demos por vencidas
J Marrugat, A Camps-Vilaró, H Tizón-Marcos
Revista Española de Cardiología 74 (9), 734-736, 2021
12021
Cardiovascular disease: still far from being beaten
J Marrugat, A Camps-Vilaró, H Tizón-Marcos
Revista espanola de cardiologia (English ed.) 74 (9), 734-736, 2021
12021
Increased risk of arrhythmias, heart failure, and thrombosis in SARS-CoV-2 positive individuals persists at one year post-infection.
C Tintore, J Cuartero, A Camps-Vilaró, I Subirana, R Elosua, J Marrugat, ...
Computational and Structural Biotechnology Journal, 2024
2024
Age-standardized comparison of cardiovascular events and all-cause mortality in people living with HIV and in general population
A Camps-Vilaro, R Teira, I Subirana, P Domingo, A Curran, MJ Galindo, ...
European Journal of Preventive Cardiology 31 (Supplement_1), 2024
2024
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study
S Polo-Alonso, A Camps-Vilaro, IR Degano, R Marti-Lluch, ...
European Journal of Preventive Cardiology 31 (Supplement_1), 2024
2024
Impact of a myocardial infarction emergency management network on population 28-day myocardial infarction case-fatality trends 2008-2019
A Camps-Vilaro, H Tizon-Marcos, IR Degano, I Subirana, ...
European Journal of Preventive Cardiology 31 (Supplement_1), 2024
2024
Increased incidence of arrhythmias, heart failure and thrombosis in COVID-19 patients after the first 3 months post-infection: a population-based cohort study
IR Degano, C Tintore, A Camps-Vilaro, I Subirana, R Elosua, J Marrugat
European Journal of Preventive Cardiology 31 (Supplement_1), 2024
2024
Optimization and validation of high, intermediate and low risk cut-off points in risk functions for primary cardiovascular prevention. The ORESTES project
N Herrera Marin, I Subirana, A Camps-Vilaro, I Palomo, J Sanchis, ...
European Journal of Preventive Cardiology 31 (Supplement_1), 2024
2024
Análisis de la incidencia y la letalidad del infarto agudo de miocardio en la provincia de Girona durante las tres últimas décadas
A Camps-Vilaró, I Subirana, R Elosua, I Palomo, J Sanchis, ...
Revista Española de Cardiología 77 (6), 450-458, 2024
2024
Measuring Cardiorespiratory Fitness without Exercise Testing: The Development and Validation of a New Tool for Spanish Adults
H Schröder, I Subirana, R Elosua, A Camps-Vilaró, H Tizón-Marcos, ...
Journal of Clinical Medicine 13 (8), 2210, 2024
2024
Genetic characteristics involved in COVID‐19 severity. The CARGENCORS case‐control study and meta‐analysis
A Camps‐Vilaró, M Pinsach‐Abuin, IR Degano, R Ramos, R Martí‐Lluch, ...
Journal of Medical Virology 96 (2), e29404, 2024
2024
Improvements in cardiovascular prevention with biomarkers in the general population and in specific risk situations
A Camps Vilaró
Universitat de Vic-Universitat Central de Catalunya, 2023
2023
Cholesterol and Hypertension Treatment Improve Coronary Risk Prediction but Not Time-Dependent Covariates or Competing Risks
I Subirana, A Camps-Vilaró, R Elosua, J Marrugat, H Tizón-Marcos, ...
Clinical Epidemiology, 1145-1154, 2022
2022
Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study
A Camps-Vilaro, I R Degano, R Brugada, M Pinsach, R Elosua, R Ramos, ...
European Heart Journal 43 (Supplement_2), ehac544. 2296, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20